Remote Exercise Video Adaptations to Maximize Physical Activity in Childhood Cancer

May 22, 2024 updated by: St. Jude Children's Research Hospital

The goal of this observational study is to leverage childhood cancer survivor input to adapt video content of a digital video disc-(DVD) delivered evidence-based PA intervention, originally designed for community-dwelling older adults.

Primary Objective:

- To leverage childhood cancer survivor input to adapt video content for an evidence-based remote exercise intervention.

Study Overview

Status

Recruiting

Detailed Description

This study is being done to update existing exercise videos to suit adult survivors of childhood cancer to help them exercise at home. Patients will be asked to watch exercise videos designed for older adults and provide feedback during an interview to help researchers update the videos to childhood cancer survivors' preferences

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Tennessee
      • Memphis, Tennessee, United States, 38105
        • Recruiting
        • St. Jude Children's Research Hospital
        • Contact:
          • Kirsten Ness, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Long-term childhood cancer survivors with low physical activity.

Description

Inclusion Criteria:

  • Participants enrolled in the St. Jude Lifetime Cohort (SJLIFE), aged 18- 39.
  • Identifies as low active (self-reports <2 days/week of Physical Activity (PA) for at least 30 minutes over the past 6 months.
  • Participant or legal guardian is able and willing to give informed consent.
  • Internet access

Exclusion Criteria:

  • Individuals who cannot speak, read, and/or understand English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative interviews
Time Frame: Day 1
Semi-structured qualitative interviews will be utilized to collect participants' perspectives on relatability, functionality, and relevance of the exercise videos to childhood cancer survivors.
Day 1
System Usability Scale Questionnaire
Time Frame: Day 1
Multi-item Likert scored questionnaire to collect participants' perspectives on usability and relevance of the exercise videos. SUS scoring starts by calculating the sum of the score contributions from each item. Each item's score contribution will range from 0 to 4. For items 1,3,5,7,and 9 the score contribution is the scale position minus 1. For items 2,4,6,8 and 10, the contribution is 5 minus the scale position. Multiply the sum of the scores by 2.5 to obtain the overall value of SU. SUS scores have a range of 0 to 100.
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kristen Ness, PT, PhD, St. Jude Children's Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

May 8, 2024

First Submitted That Met QC Criteria

May 8, 2024

First Posted (Actual)

May 13, 2024

Study Record Updates

Last Update Posted (Estimated)

May 24, 2024

Last Update Submitted That Met QC Criteria

May 22, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REVAMP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

3
Subscribe